Dallas, TX – According to filings with the U.S. Securities and Exchange Commission, CerSci Therapeutics is raising $8,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Lucas Rodriguez played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CerSci Therapeutics

CerSci Therapeutics was founded to deliver much needed new medicines through understanding the underlying mechanisms behind pain, and by conquering the core problem of neuronal sensitization. Rather than concentrating on ion channel and GPCR targets that blunt pain, our science is focused on interrupting pathways that cause neuronal sensitization, the cause of pain.

To learn more about CerSci Therapeutics, visit http://cersci.com/

Contact:
Lucas Rodriguez, Chief Executive Officer
214-306-6218
lucas@cersci.com
https://www.linkedin.com/in/lucas-rodriguez-9b64b448/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved